Drugs / S-1
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT04250948 Background | Oct 2019 → Jun 2022 | gastric cancer | Sun Yat-sen University | Unknown | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | S-1 | “S-1: 40\~60mg Bid，d1\~14, q3w” NCT04250948 ↗ |
| Known as | S-1: 40\~60mg Bid，d1\~14, q3w | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04250948 ↗ |